Zimmer Biomet (ZBH) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results ...

Musculoskeletal product breadth supports procedural demand Global healthcare footprint remains diversified Broader market ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is included on our list of the best undervalued wide moat stocks. On January 13, 2026, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) laid out cautious expectations ...

Over the past six months, Zimmer Biomet’s shares (currently trading at $86.64) have posted a disappointing 6.2% loss, well below the S&P 500’s 9.6% gain. This might have investors contemplating their ...

Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its G7 acetabular system for hip ...

Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.

Is On Investors’ Radar Today Zimmer Biomet Holdings (ZBH) is back in focus after recent share price moves, with the stock showing a negative 1 day return and mixed performance over the past week, ...

Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better ...

We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the worst-performing stocks on Wednesday. Zimmer dropped its share prices by 15.15 ...

Investors interested in Medical - Products stocks are likely familiar with Zimmer Biomet (ZBH) and LeMaitre Vascular (LMAT). But which of these two stocks is more attractive to value investors? We'll ...